These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15637612)

  • 1. Time to kick that drug habit.
    Jacobs T
    Nat Biotechnol; 2005 Jan; 23(1):23. PubMed ID: 15637612
    [No Abstract]   [Full Text] [Related]  

  • 2. Minicrash tests biotechnology investors and companies as market fluctuates.
    Dorey E
    Nat Biotechnol; 1997 Dec; 15(13):1333. PubMed ID: 9415878
    [No Abstract]   [Full Text] [Related]  

  • 3. Investing in oncology biotech stocks.
    Feuerstein A
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):879-80. PubMed ID: 18185485
    [No Abstract]   [Full Text] [Related]  

  • 4. Kick-starting biotechnology in Ontario.
    Endersby JM
    Nat Biotechnol; 1999 May; 17(5):444-6. PubMed ID: 10331800
    [No Abstract]   [Full Text] [Related]  

  • 5. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 6. Australian biotech suffers growing pains.
    O'Neill G
    Nat Biotechnol; 2005 Apr; 23(4):401-2. PubMed ID: 15815652
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotechnologies to watch.
    Persidis A
    Nat Biotechnol; 1997 Dec; 15(13):1409-11. PubMed ID: 9415897
    [No Abstract]   [Full Text] [Related]  

  • 8. Kiran Mazumdar-Shaw.
    Jayaraman KS
    Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
    [No Abstract]   [Full Text] [Related]  

  • 9. France critiques its incubator before refinancing.
    Louët S
    Nat Biotechnol; 2004 Jan; 22(1):126. PubMed ID: 14725299
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmas partner in venture seeking drug discovery tools.
    Mack GS
    Nat Biotechnol; 2008 Sep; 26(9):960-1. PubMed ID: 18779790
    [No Abstract]   [Full Text] [Related]  

  • 11. Little biotech on the prairie.
    Wolfson W
    Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
    [No Abstract]   [Full Text] [Related]  

  • 12. White biotech and the financial crisis.
    Rabinovich M
    Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
    [No Abstract]   [Full Text] [Related]  

  • 13. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there balm in Gilead?
    Jacobs T
    Nat Biotechnol; 2006 Dec; 24(12):1478. PubMed ID: 17160040
    [No Abstract]   [Full Text] [Related]  

  • 15. PEGging biotech growth.
    Jacobs T
    Nat Biotechnol; 2006 May; 24(5):506. PubMed ID: 16680127
    [No Abstract]   [Full Text] [Related]  

  • 16. No pain, no gain?
    Jacobs T
    Nat Biotechnol; 2005 Aug; 23(8):934. PubMed ID: 16082357
    [No Abstract]   [Full Text] [Related]  

  • 17. Any diamonds in the diagnostic coal?
    Jacobs T
    Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology. 'Silber's folly' goes public.
    Anderson C
    Nature; 1992 Mar; 356(6366):183. PubMed ID: 1552932
    [No Abstract]   [Full Text] [Related]  

  • 20. Gold in the ivory tower: equity rewards of outlicensing.
    Edwards M; Murray F; Yu R
    Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.